Comparative pilot study about HPV test with partial genotyping in primary screening versus other strategies for cervical cancer population screening, CRYGEN 16/18 study-Reference-Cited by-同舟云学术

Comparative pilot study about HPV test with partial genotyping in primary screening versus other strategies for cervical cancer population screening, CRYGEN 16/18 study

Published:2023-05 Issue:5 Volume:41 Page:262-268
ISSN:2529-993X
Container-title:Enfermedades infecciosas y microbiologia clinica (English ed.)
language:en
Short-container-title:Enfermedades infecciosas y microbiologia clinica (English ed.)

Author:

Hernández-Aguado Juan J.,de La Fuente-Valero Jesús,Ramírez Mena Mar,Ortega-Medina Luis,Vidart Aragón José Antonio,Galán Juan Carlos

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Improving data for decision-making: a toolkit for cervical cancer prevention and control programmes;World Health Organization,2018

2. International HPV screening working group. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials;Ronco;Lancet,2014

3. European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination;Von Karsa;Papillomavirus Res,2015

4. European guidelines for quality assurance in cervical cancer screening. 2nd ed. Supplements. [Accessed 29 March 2021]. Available in: https://op.europa.eu/en/publication-detail/-/publication/a41a4c40-0626-4556-af5b-2619dd1d5ddc/language-en.

5. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study;de Sanjose;Lancet Oncol,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA extended interventional nucleic acid longitudinal study: Clinical performance of Aptima messenger RNA HPV testing in cervical cancer screening with a 9‐year follow‐up;Cancer Cytopathology;2024-08-19